O
OrbiMed Portfolio holdings
AUM
$3.98B
This Quarter Return
+32.08%
1 Year Return
+13.05%
3 Year Return
+159.74%
5 Year Return
+207.27%
10 Year Return
+1,027.33%
AUM
$4.99B
AUM Growth
+$4.99B
(+7.1%)
Cap. Flow
-$375M
Cap. Flow
% of AUM
-7.51%
Top 10 Holdings %
Top 10 Hldgs %
36.59%
Holding
136
New
14
Increased
17
Reduced
27
Closed
25
Top Buys
| 1 |
Eli Lilly
LLY
|
$105M |
| 2 |
Biogen
BIIB
|
$70.1M |
| 3 |
Elevance Health
ELV
|
$66.7M |
| 4 |
Scholar Rock
SRRK
|
$41.6M |
| 5 |
argenx
ARGX
|
$19.8M |
Top Sells
| 1 |
Humana
HUM
|
$106M |
| 2 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$85.3M |
| 3 |
Baxter International
BAX
|
$84.5M |
| 4 |
Cigna
CI
|
$66.2M |
| 5 |
AbbVie
ABBV
|
$49.2M |
Sector Composition
| 1 | Healthcare | 98.25% |
| 2 | Industrials | 1.02% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Arrowhead Research
ARWR
$3.84B
| $9.78M | 0.2% |
319,651
-114,000
| -26% | -$3.49M |
|
77
uniQure
QURE
$954M
| $9.13M | 0.18% |
1,347,900
-716,555
| -35% | -$4.85M |
|
78
DexCom
DXCM
$30.9B
| $9.08M | 0.18% |
+73,200
| New | +$9.08M |
|
79
Apollomics
APLM
$4.62M
| $8.27M | 0.17% |
8,565,456
-9,428,179
| -52% | -$9.1M |
|
80
Gilead Sciences
GILD
$140B
| $8.1M | 0.16% |
100,000
| – | – |
|
|
MORF
81
DELISTED
Morphic Holding, Inc. Common Stock
MORF
| $7.9M | 0.16% |
273,400
+64,900
| +31% | +$1.87M |
|
|
TSBX
82
DELISTED
Turnstone Biologics
TSBX
| $7.89M | 0.16% |
3,099,265
| – | – |
|
83
RAPT Therapeutics
RAPT
$187M
| $6.99M | 0.14% |
281,413
-963,532
| -77% | -$23.9M |
|
|
IMA
84
ImageneBio, Inc. Common Stock
IMA
$153M
| $6.97M | 0.14% |
3,539,358
+353,192
| +11% | +$696K |
|
85
InspireMD
NSPR
$101M
| $5.99M | 0.12% |
2,133,405
+273,000
| +15% | +$767K |
|
86
X4 Pharmaceuticals
XFOR
$70M
| $5.98M | 0.12% |
7,133,515
| – | – |
|
87
Cullinan Oncology
CGEM
$456M
| $5.55M | 0.11% |
544,848
| – | – |
|
88
Oric Pharmaceuticals
ORIC
$1.03B
| $4.81M | 0.1% |
522,968
-370,700
| -41% | -$3.41M |
|
89
Illumina
ILMN
$15.2B
| $4.22M | 0.08% |
+30,300
| New | +$4.22M |
|
|
AMAM
90
DELISTED
Ambrx Biopharma, Inc. Common Stock
AMAM
| $4.22M | 0.08% |
+296,000
| New | +$4.22M |
|
91
NextCure
NXTC
$13.3M
| $3.09M | 0.06% |
2,711,013
| – | – |
|
92
Celldex Therapeutics
CLDX
$1.57B
| $2.33M | 0.05% |
+58,800
| New | +$2.33M |
|
93
Arcus Biosciences
RCUS
$1.24B
| $2.23M | 0.04% |
+117,000
| New | +$2.23M |
|
94
10x Genomics
TXG
$1.66B
| $2.23M | 0.04% |
+39,800
| New | +$2.23M |
|
95
Fate Therapeutics
FATE
$115M
| $1.98M | 0.04% |
+528,080
| New | +$1.98M |
|
96
Kezar Life Sciences
KZR
$28.5M
| $1.83M | 0.04% |
1,927,000
-3,536,000
| -65% | -$3.35M |
|
97
Bolt Biotherapeutics
BOLT
$9.29M
| $1.73M | 0.03% |
1,541,000
| – | – |
|
|
LSB
98
LakeShore Biopharma
LSB
$34.9M
| $1.65M | 0.03% |
3,236,311
-1,305,111
| -29% | -$667K |
|
|
VIGL
99
DELISTED
Vigil Neuroscience
VIGL
| $1.52M | 0.03% |
448,891
| – | – |
|
100
BiomX
PHGE
$14.1M
| $1.26M | 0.03% |
4,517,589
-35,900
| -0.8% | -$10.1K |
|